Prueksaritanont T - Search Results

1

Effect of P-glycoprotein-mediated efflux on cerebrospinal fluid concentrations in rhesus monkeys.

Tang C, Kuo Y, Pudvah NT, Ellis JD, Michener MS, Egbertson M, Graham SL, Cook JJ, Hochman JH, Prueksaritanont T. Tang C, et al. Among authors: prueksaritanont t. Biochem Pharmacol. 2009 Sep 15;78(6):642-7. doi: 10.1016/j.bcp.2009.05.026. Epub 2009 May 27. Biochem Pharmacol. 2009. PMID: 19481060

2

Interactions of human P-glycoprotein with simvastatin, simvastatin acid, and atorvastatin.

Hochman JH, Pudvah N, Qiu J, Yamazaki M, Tang C, Lin JH, Prueksaritanont T. Hochman JH, et al. Among authors: prueksaritanont t. Pharm Res. 2004 Sep;21(9):1686-91. doi: 10.1023/b:pham.0000041466.84653.8c. Pharm Res. 2004. PMID: 15497697

3

In vitro and in vivo CYP3A64 induction and inhibition studies in rhesus monkeys: a preclinical approach for CYP3A-mediated drug interaction studies.

Prueksaritanont T, Kuo Y, Tang C, Li C, Qiu Y, Lu B, Strong-Basalyga K, Richards K, Carr B, Lin JH. Prueksaritanont T, et al. Drug Metab Dispos. 2006 Sep;34(9):1546-55. doi: 10.1124/dmd.106.009878. Epub 2006 Jun 16. Drug Metab Dispos. 2006. PMID: 16782766

4

Rifampin induces the in vitro oxidative metabolism, but not the in vivo clearance of diclofenac in rhesus monkeys.

Prueksaritanont T, Li C, Tang C, Kuo Y, Strong-Basalyga K, Carr B. Prueksaritanont T, et al. Drug Metab Dispos. 2006 Nov;34(11):1806-10. doi: 10.1124/dmd.106.011643. Epub 2006 Aug 23. Drug Metab Dispos. 2006. PMID: 16928785

5

CYP2C75-involved autoinduction of metabolism in rhesus monkeys of methyl 3-chloro-3'-fluoro-4'-{(1R)-1-[({1-[(trifluoroacetyl)amino]cyclopropyl}carbonyl)amino]ethyl}-1,1'-biphenyl-2-carboxylate (MK-0686), a bradykinin B1 receptor antagonist.

Tang C, Carr BA, Poignant F, Ma B, Polsky-Fisher SL, Kuo Y, Strong-Basalyga K, Norcross A, Richards K, Eisenhandler R, Carlini EJ, Di Marco CN, Kuduk SD, Yu NX, Raab CE, Rushmore T, Frederick CB, Bock MG, Prueksaritanont T. Tang C, et al. Among authors: prueksaritanont t. J Pharmacol Exp Ther. 2008 Jun;325(3):935-46. doi: 10.1124/jpet.107.136044. Epub 2008 Feb 29. J Pharmacol Exp Ther. 2008. PMID: 18310472

6

Theoretical analysis of interplay of therapeutic protein drug and circulating soluble target: temporal profiles of 'free' and 'total' drug and target.

Tang C, Prueksaritanont T. Tang C, et al. Among authors: prueksaritanont t. Pharm Res. 2011 Oct;28(10):2447-57. doi: 10.1007/s11095-011-0471-0. Epub 2011 May 26. Pharm Res. 2011. PMID: 21614635

7

Differences in the absorption, metabolism and biliary excretion of a diastereomeric pair of alphavbeta3-antagonists in rat: limited role of P-glycoprotein.

Prueksaritanont T, Meng Y, Ma B, Leppert P, Hochman J, Tang C, Perkins J, Zrada M, Meissner R, Duggan ME, Lin JH. Prueksaritanont T, et al. Xenobiotica. 2002 Mar;32(3):207-20. doi: 10.1080/00498250110094403. Xenobiotica. 2002. PMID: 11958560

8

Renal elimination of a novel and potent alphavbeta3 integrin antagonist in animals.

Prueksaritanont T, Hochman JH, Meng Y, Pudvah NT, Barrish A, Ma B, Yamazaki M, Fernandez-Metzler C, Lin JH. Prueksaritanont T, et al. Xenobiotica. 2004 Nov-Dec;34(11-12):1059-74. doi: 10.1080/00498250400015277. Xenobiotica. 2004. PMID: 15801548

9

Effects of fibrates on human organic anion-transporting polypeptide 1B1-, multidrug resistance protein 2- and P-glycoprotein-mediated transport.

Yamazaki M, Li B, Louie SW, Pudvah NT, Stocco R, Wong W, Abramovitz M, Demartis A, Laufer R, Hochman JH, Prueksaritanont T, Lin JH. Yamazaki M, et al. Among authors: prueksaritanont t. Xenobiotica. 2005 Jul;35(7):737-53. doi: 10.1080/00498250500136676. Xenobiotica. 2005. PMID: 16316932

10

Development of orally bioavailable and CNS penetrant biphenylaminocyclopropane carboxamide bradykinin B1 receptor antagonists.

Kuduk SD, Di Marco CN, Chang RK, Wood MR, Schirripa KM, Kim JJ, Wai JM, DiPardo RM, Murphy KL, Ransom RW, Harrell CM, Reiss DR, Holahan MA, Cook J, Hess JF, Sain N, Urban MO, Tang C, Prueksaritanont T, Pettibone DJ, Bock MG. Kuduk SD, et al. Among authors: prueksaritanont t. J Med Chem. 2007 Jan 25;50(2):272-82. doi: 10.1021/jm061094b. J Med Chem. 2007. PMID: 17228869

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

144 results

Search Page

Filters